Table 5 Treatments received after first treatment during follow-up period (Cohort B )
| Â | Â | First treatment after catheterization | |||||
|---|---|---|---|---|---|---|---|
Medical | CABG | PCI | |||||
N | % | N | % | N | % | ||
Secondary treatment | None | 1818 | 85.6 | 487 | 87.1 | 1359 | 86.9 |
PCI | 95 | 4.5 | 39 | 7.0 | 59 | 3.8 | |
CABG | 124 | 5.8 | 21 | 3.8 | 73 | 4.7 | |
Lytic | 56 | 2.6 | 3 | 0.5 | 47 | 3.0 | |
PCI & Lytic | 1 | 0.0 | 0 | 0.0 | 3 | 0.2 | |
CABG & Lytic | 0 | 0.0 | 0 | 0.0 | 1 | 0.1 | |
PCI & CABG | 28 | 1.3 | 7 | 1.3 | 21 | 1.3 | |
PCI & CABG & Lytic | 1 | 0 | 2 | 0.4 | 1 | 0.1 | |
Total | Â | 2123 | 100.0 | 559 | 100.0 | 1564 | 100.0 |